Back
A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients with Recurrent Glioblastoma Multiforme: Final Report (Protocol BT-21)
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski
J. Cancer Ther. Vol.5 No.10, September 10, 2014  DOI: 10.4236/jct.2014.510100
       (PDF  2876K)     HTML     
Recurrent Glioblastoma Multiforme—A Strategy for Long-Term Survival
Stanislaw R. Burzynski, Gregory S. Burzynski, Tomasz J. Janicki
J. Cancer Ther. Vol.5 No.10, September 10, 2014  DOI: 10.4236/jct.2014.510101
       (PDF  3800K)     HTML     
Protracted Adjuvant Temozolomide in Glioblastoma Multiforme
Ahmed A. Refae, Ahmed Ezzat, Dina Ahmed Salem, Mervat Mahrous
J. Cancer Ther. Vol.6 No.8, August 14, 2015  DOI: 10.4236/jct.2015.68082
       (PDF  567K)     HTML      XML
Complete Remission and Long Term Survival in Recurrent Malignant Glioblastoma Treated with Fotemustine Monotherapy: A Case Report
Carmine Cerullo, Carla Fonte, Andrea Muto, Agnese Vannini, Mattia Rediti, Sheila Rangan, Lorenzo Bordi, Bruno Neri
J. Cancer Ther. Vol.4 No.2, April 19, 2013  DOI: 10.4236/jct.2013.42075
       (PDF  824K)     HTML      XML
Preliminary Findings on the Use of Targeted Therapy with Pazopanib and Other Agents in Combination with Sodium Phenylbutyrate in the Treatment of Glioblastoma Multiforme
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Sheldon Brookman
J. Cancer Ther. Vol.5 No.14, December 25, 2014  DOI: 10.4236/jct.2014.514144
       (PDF  3746K)     HTML      XML
 
 
Top